Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 11Gowling WLG (Canada) LLP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Pharmaconex
Not Confirmed
arrow
Pharmaconex
Not Confirmed

Canakinumab

Brand Name : ILARIS

Patent Number : 2420231

Filing Date : 2001-08-20

Strength per Unit : 150 mg / mL

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2021-08-20

Date Granted : 2011-04-26

blank

02

arrow
Pharmaconex
Not Confirmed
arrow
Pharmaconex
Not Confirmed

Canakinumab

Brand Name : ILARIS

Patent Number : 2626214

Filing Date : 2006-10-24

Strength per Unit : 150 mg / mL

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2026-10-24

Date Granted : 2016-06-21

blank

03

arrow
Pharmaconex
Not Confirmed
arrow
Pharmaconex
Not Confirmed

Canakinumab

Brand Name : ILARIS

Patent Number : 2420231

Filing Date : 2001-08-20

Strength per Unit : 150 mg / 1mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2021-08-20

Date Granted : 2011-04-26

blank

04

Gowling WLG (Canada) LLP

arrow
Pharmaconex
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
Pharmaconex
Not Confirmed

Canakinumab

Brand Name : ILARIS

Patent Number : 2898369

Filing Date : 2006-10-24

Strength per Unit : 150 mg / mL

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2026-10-24

Date Granted : 2017-06-20

blank

05

Gowling WLG (Canada) LLP

arrow
Pharmaconex
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
Pharmaconex
Not Confirmed

Canakinumab

Brand Name : ILARIS

Patent Number : 2687499

Filing Date : 2008-05-28

Strength per Unit : 150 mg / mL

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2028-05-28

Date Granted : 2017-11-28

blank

06

Gowling WLG (Canada) LLP

arrow
Pharmaconex
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
Pharmaconex
Not Confirmed

Canakinumab

Brand Name : ILARIS

Patent Number : 2947947

Filing Date : 2008-05-28

Strength per Unit : 150 mg / mL

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2028-05-28

Date Granted : 2018-03-06

blank

07

Gowling WLG (Canada) LLP

arrow
Pharmaconex
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
Pharmaconex
Not Confirmed

Canakinumab

Brand Name : ILARIS

Patent Number : 2898369

Filing Date : 2006-10-24

Strength per Unit : 150 mg / 1mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2026-10-24

Date Granted : 2017-06-20

blank

08

Gowling WLG (Canada) LLP

arrow
Pharmaconex
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
Pharmaconex
Not Confirmed

Canakinumab

Brand Name : ILARIS

Patent Number : 2687499

Filing Date : 2008-05-28

Strength per Unit : 150 mg / 1mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2028-05-28

Date Granted : 2017-11-28

blank

09

Gowling WLG (Canada) LLP

arrow
Pharmaconex
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
Pharmaconex
Not Confirmed

Canakinumab

Brand Name : ILARIS

Patent Number : 2947947

Filing Date : 2008-05-28

Strength per Unit : 150 mg / 1mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2028-05-28

Date Granted : 2018-03-06

blank

10

Gowling WLG (Canada) LLP

arrow
Pharmaconex
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
Pharmaconex
Not Confirmed

Canakinumab

Brand Name : ILARIS

Patent Number : 2745938

Filing Date : 2009-12-09

Strength per Unit : 150 mg / 1mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2029-12-09

Date Granted : 2018-04-24

blank